Related Experiment Video
Updated: Feb 26, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
Pulmonary infections in the returned traveller
Ashleigh Trimble1,2, V Moffat3, A M Collins2,4
1Crosshouse Hospital, Kilmarnock Road, Crosshouse, KA2 0BE UK.
Diagnosing and treating pulmonary infections in returned travelers is crucial. This review covers various travel-related lung diseases, their causes, and clinical approaches.
Area of Science:
- Infectious Diseases
- Pulmonology
- Travel Medicine
Background:
- Pulmonary infections are a frequent reason for medical consultation in travelers returning from abroad.
- A diverse range of infectious agents can cause lung symptoms in this population.
- Identifying the specific cause is essential for effective management.
Purpose of the Study:
- To outline a systematic approach for diagnosing pulmonary infections in returned travelers.
- To discuss the treatment strategies for various travel-related lung diseases.
- To highlight the influence of travel destination, duration, activities, and host factors on disease risk.
Main Methods:
- This is a review article.
- It synthesizes current knowledge on diagnosing and treating pulmonary infections in returned travelers.
- It discusses the epidemiology and clinical presentation of relevant pathogens.
Main Results:
- The risk of acquiring specific pulmonary infections is influenced by travel-related factors and individual comorbidities.
- Pathogen distribution varies geographically, with some being globally prevalent and others location-specific.
- A structured diagnostic and therapeutic approach is necessary.
Conclusions:
- Pulmonary infections in returned travelers require careful clinical evaluation.
- Understanding travel history is paramount for identifying potential etiologies.
- Prompt and appropriate management can improve patient outcomes.
More Related Videos
03:22Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE
Published on: March 1, 2024
10:26P. aeruginosa Infected 3D Co-Culture of Bronchial Epithelial Cells and Macrophages at Air-Liquid Interface for Preclinical Evaluation of Anti-Infectives
Published on: June 15, 2020
Related Concept Videos
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pneumonia III: Complications and Assessment
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...